Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Exactech Announces First Total Ankle Surgeries in South America

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced first surgeries in Latin America with the Vantage® Total Ankle Fixed Bearing System.

Manuel Pellegrini, MD, and Giovanni Carcuro, MD, of the Clinica Universidad de los Andes, performed the bilateral ankle procedures in Chile earlier this month.

“Many patients worldwide are benefitting from the Vantage Ankle, and I’m honored to be the first to use it on my continent,” said Dr. Pellegrini. “My patient not only received one, but two Exactech implants, and I look forward to seeing their progress post-surgery.”

The Vantage Ankle was first launched in the U.S. in 2016 and received clearance in Chile earlier this year. It is designed to recreate the natural biomechanics of the ankle joint through its curved talus component, which aligns with the talus’ trabecular bone structure, and tibial implant. Specifically, the press-fit tibial component is designed for anatomic cortical coverage and fibular articulation and features a center bone cage and three plasma pegs that are engineered to create initial fixation.1 In addition, the system features a polyethylene liner and a unique locking clip for secure fastening of the polyethylene liner.

“We are thrilled to be part of this landmark procedure,” said Foot and Ankle Marketing Director Devan Carter. “The Vantage Ankle has helped many patients get back to what they love doing, and we’re happy to share these clinical results with patients and surgeons in Chile. We hope to expand into other Latin American countries in the future.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy